ELIGIBILITY:

This program is open to licensed African physicians with a faculty appointment, who are currently working at an African academic institution. It is open to physicians from all specialties and primary care who seek a specific skill to improve health outcomes at their institution. However, we will prioritize those from Sub-Saharan Africa interested in the fields of antimicrobial resistance, oncology, vaccine uptake or inflammatory diseases.

To be considered, applicants must meet all the following eligibility criteria:

Be in good standing within their institutions and demonstrate an ongoing commitment to improving health outcomes in their home countries.

Be an African citizen* who is currently living, teaching and practicing clinically in an African country.

Be a board-certified medical doctor with one of the following degrees: MD, MBChB or MMed.

Be a mid-career physician, appointed as a faculty member for at least 3 and less than 15 years.

Have strong working proficiency in written and spoken English (as determined by the selection committee).

BENEFIT:

The program includes/provides:

Visa costs

Living expenses while at Stanford during Phase 1

Honorarium for Phase 1

Travel to and from a San Francisco regional airport, economy class roundtrip airfare for the awardee only, and associated travel costs to Stanford for Phase 1

Up to $50,000 in grant funding from Pfizer provided directly to scholars’ academic institutions for phase 2 project implementation. These funds cannot be used to purchase capital equipment.*